SBIR/STTR Research Award
Statistical Methods for Evaluating Longitudinal Biomarkers in Treatment Selection and Diagnostic Tests
Award amount
$254,404Program and phase
SBIR · Phase IAward year
2019Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- Data Numerica Institute, Inc.
- Proposal award date
- 2019-09-04
- Contract end date
- 2020-06-03
- UEI
- Not reported
- Solicitation number
- PA18-574
- Topic code
- 400
Research abstract
In this researchwe will study two related statistical topics aiming at evaluating longitudinal biomarkers that have impacts on clinical outcome and individualized medical decisionThe results of this study will be applicable to classifying patientsresponse rates based on marker evaluationpredicting disease onsetand selecting treatment protocol that would benefit individual patientsIn treating colon cancerthe patientssurvival rates might be associated with the interaction of surgery and biomarkerse gc myc gene expression levelsIn HIV studiesHIVRNA and CDlevels may result in different outcomes for various treatment groupsSuch biomarkers could be indicators predictors of which patient groups may benefit more from specific treatment optionsMarker evaluation methods and tools are critical in finding the optimal treatment protocol for patientsWe will develop a comprehensive and user friendly environment for analyzing marker dataand the first goal focuses on marker evaluation in treatment selectionTypicallya selection criterion is based on a threshold of a markerAn innovative approach is to evaluate a selection policy by the Selection ImpactSIscore based on the treatment assignment proportion of a given thresholdBy plotting such proportions and the SI score of a given thresholdone can easily find the optimal threshold of biomarker as well as the best marker in marker comparisonOur second goal focuses on the classification capability of markers in selecting diagnostic tests based on marker valuesReceiver Operating CharacteristicsROCcurve is the traditional method in evaluating images in radiological studiesThe challenges are that the level of biomarker may vary over time and the clinical outcome might be a time toevent with censored valuesTypicallythe conventional image diagnostic tests focus on binary outcome with fixed marker values at the baselinee gpositive or negative results in tumor evaluationWe will emphasize more on ROC curve for longitudinal markers and survival outcomeAt the endwe will develop various methods for SI and ROC curves and integrate them into a user friendly statistical softwareWith such toolswe will promote the applications of time varying markers and predictors in personalized treatment decision This project will provide statistical software with advanced methods useful for marker selectionevaluationand personalized treatmentStatistical methodsgraphicscomputational environment and case studies will be developed
Technology keywords
Not reported
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Platform for Optimizing Yield and Quality of Therapeutic AAV Vector Manufacturing via Synthetic Helper Genes
- Ultra-low-temperature (6 K) static NMR-DNP for metalloproteins, proteins in cells, and materials
- Dynamical Diffraction Analysis for 3D Electron Crystallography
- Synthetic biology approaches for bio-orthogonal labeling of circular RNAs
- Break Wave lithotripsy to fragment large kidney stones